The cytoplasmic components and nuclear effectors mediating growth factor/Ras-induced gene expression are common to all cell types. Thus, defining the precise molecular mechanisms by which ubiquitous components of growth factor/Ras signaling pathways result in cell-specific responses remains a central problem in biology today. Previously, we discovered an elegant and precise tri-paritite molecular code, involving the proto-oncoprotein c-Ets-1, the POUhomeodomain protein Pit-l, and a composite DNA element containing an Ets binding site (EBS) adjacent to a Pit-1 site (FPIV). Pit-l, Ets-1 and this composite site were shown to be required not only for the Ras response of the rat (r) prolactin (PRL) promoter, but also to reconstitute lactotroph-specific rPRL promoter activity. This was the first and remains the only example of a tissue-specific Ras response element (RRE). During the past funding cycle, we used NMR and GST pull-down methods to map the Ets-1/Pit-1 interaction surfaces to exact residues on the Pit-1 POUhomeodomain and to the Ets-1 RIII TAD. We reported that Ets-1 preferentially binds to the EBS in the RRE, whereas GABP preferentially binds to the BTE/EBS centered at -95. Finally, using dominant-negative and siRNA approaches, we verified that Ets factors, in particular GABP, are critical for basal and growth factor-induced rPRL promoter activity. These studies revealed that Ets-1 and GABP are critical for lactotroph-specific expression of the endogenous rPRL gene. While our previous studies have mostly used reporter gene assays, the broad mandate of this proposal is to use molecular, biochemical and transgenic approaches to dissect the physiological role of select Ets factors and Ets factor binding sites in goveming basal and Ras-regulated lactotroph-specific expression of the endogenous rPRL gene in GH4 cells and in mice. Unifying Hypothesis: We hypothesize that basal and Ras-regulated expression of the lactotroph-specific rPRL gene is governed by specific Ets factors, some acting in concert with Pit-l, whose binding to Ets binding sites on the proximal rPRL promoter is regulated by the physiological state of the cell.
Specific Aims : (1) To identify Ets factor occupancy on the endogenous, proximal rPRL promoter in GH4 rat pituitary cells q oncogenic Ras. (2) To identify the oncogenie Ras-dependent protein components of Ets-1/Pit-1 transcription factor complexes. (3) To determine the functional role of basal and oncogenic Ras-regulated transcription co-regulatory molecules (4) To elucidate the physiological role of rPRL Ets binding sites and the Ets factor GABP in PRL gene expression in transgenic mice. Information gained from these studies will provide critical insights into the mechanisms by which combinatorial Ets/Pit-1 protein interactions specify cell-restricted PRL gene expression, and also provide a novel insights into the mechanisms by which Ras/MAPK regulates gene expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK046868-11
Application #
6748487
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Blondel, Olivier
Project Start
1994-06-01
Project End
2007-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
11
Fiscal Year
2004
Total Cost
$368,029
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Roof, Allyson K; Trudeau, Tammy; Gutierrez-Hartmann, Arthur (2018) Pituitary somatolactotropes evade an oncogenic response to Ras. Mol Cell Endocrinol 476:165-172
Roof, Allyson K; Jirawatnotai, Siwanon; Trudeau, Tammy et al. (2018) The Balance of PI3K and ERK Signaling Is Dysregulated in Prolactinoma and Modulated by Dopamine. Endocrinology 159:2421-2434
Booth, Allyson; Trudeau, Tammy; Gomez, Crystal et al. (2014) Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype. Mol Endocrinol 28:1999-2011
Jean, Annie; Gutierrez-Hartmann, Arthur; Duval, Dawn L (2010) A Pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit Ras and estrogen stimulation of the prolactin gene promoter. Mol Endocrinol 24:91-103
Jedlicka, Paul; Sui, Xiaomei; Gutierrez-Hartmann, Arthur (2009) The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice. BMC Cancer 9:197
Jedlicka, Paul; Sui, Xiaomei; Sussel, Lori et al. (2009) Ets transcription factors control epithelial maturation and transit and crypt-villus morphogenesis in the mammalian intestine. Am J Pathol 174:1280-90
Gutierrez-Hartmann, Arthur; Duval, Dawn L; Bradford, Andrew P (2007) ETS transcription factors in endocrine systems. Trends Endocrinol Metab 18:150-8
Ferry, A L; Locasto, D M; Meszaros, L B et al. (2005) Pit-1beta reduces transcription and CREB-binding protein recruitment in a DNA context-dependent manner. J Endocrinol 185:173-85
Schweppe, Rebecca E; Melton, Alexis A; Brodsky, Kelley S et al. (2003) Purification and mass spectrometric identification of GA-binding protein (GABP) as the functional pituitary Ets factor binding to the basal transcription element of the prolactin promoter. J Biol Chem 278:16863-72
Duval, Dawn L; Jean, Annie; Gutierrez-Hartmann, Arthur (2003) Ras signaling and transcriptional synergy at a flexible Ets-1/Pit-1 composite DNA element is defined by the assembly of selective activation domains. J Biol Chem 278:39684-96

Showing the most recent 10 out of 22 publications